Navigation Links
Antibody Technologies and Attrition Rates -- an industry analysis 2013
Date:3/27/2013

Learn the influence of the target for the success rate of the selected antibody technology.

Table of Contents

1 Executive Summary and Discussion

2 Introduction 3 Methodology 4 Results 4.1 Use of antibody technologies

4.2 Attrition rates

4.3 Reasons for failure

4.4 Antibody generation technologies and targets

4.5 Antibody technologies and antibody formats

4.6 Parental animal species of in vivo generated antibodies

4.7 Immunoglobulin class and isotype vs. antibody technology

4.8 Antibody technology and therapeutic areas

4.9 Attrition rates of antibodies in therapeutic areas

4.10 Benchmark analysis: big pharma and biotech antibody technology preferences and attrition rates

5 Tables Table 1 Overall attrition rate of in vitro generated antibodies

Table 2 Overall attrition rate of in vivo generated antibodies

Table 3 Highest phase of active antibodies generated by in vitro technologies

Table 4 Highest phase of active antibodies generated by in vivo technologies

Table 5 Year of antibody failure for in vitro generated antibodies

Table 6 Year of antibody failure for in vivo generated antibodies

Table 7 Attrition rate of in vitro generated antibodies in the period 2006-2013

Table 8 Attrition rate of in vivo generated antibodies in the period 2006-2013

Table 9 Highest phase of failed antibodies generated by in vitro technologies

Table 10 Highest phase of failed antibodies generated by in vivo technologies

Tables 11 Reasons for failure of antibodies generated by in vitro technologies

Tables 12 Reasons for failure of antibodies generated by in vivo technologies

Table 13 Reasons for failure of humanized antibodies per phase

Tables 14 Targets of failed in vitro generated antibodies per technology

Tables 15 Targets vs. in vitro and in vivo antibody generation technologies

<
'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. iBio Adds New Therapeutic Antibody to Its Pipeline
2. Glenmark Announces a New Discovery and the Initiation of IND Enabling Studies of a Novel Monoclonal Antibody Targeting OX40
3. Monoclonal Antibody Partnering Terms & Agreements Discussed in New Report Now Available at MarketPublishers.com
4. GeneTex Launches New Antibody Against Phosphorylated Histone H3 for Epigenetics Research
5. NKT Therapeutics Presents Data on Potential Antibody Treatment for Sickle Cell Disease
6. Ebola antibody treatment, produced in plants, protects monkeys from lethal disease
7. Preclinical data shows 100 percent prevention and treatment of influenza with engineered human antibody
8. Oncobiologics, Inc. Announces a Collaboration Agreement with XOMA Corporation to Utilize XOMAs Fully Human Antibody Libraries for Their Discovery Platform
9. Sanofi and Regeneron Launch Comprehensive Phase 3 Clinical Program With LDL Cholesterol-Lowering PCSK9 Antibody
10. RayBiotech, Inc. and the University of Oslo Enter into Antibody Array Services Collaboration
11. Sinovac to Present at 55th Annual BioPharma China Convention 2012 - Vaccine & Antibody Focus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... laureate Herbert Kroemer famously observed, referring to the ... where layers of different materials meet. In today,s ... of metal oxides are becoming increasingly prominent, with ... superconductors, ferroelectrics and multiferroics. Realizing the vast potential ...
(Date:1/15/2014)... January 15, 2014 Look inside the ... items for the lab, from fluid handling to instruments ... to ship when you order. , Preferred Solutions ... , from the L/S® model for precise flow control ...
(Date:1/15/2014)... Canada (PRWEB) January 15, 2014 This ... on nonclinical and clinical safety assessment in biosimilars. , ... path for biosimilar drug development, however the complex nature ... to quality, safety and efficacy extremely challenging. Based on ...
(Date:1/15/2014)... The Microcompetition with Foreign DNA theory explains ... these latent viruses is the Epstein Barr Virus (EBV), and ... (RA) is a chronic inflammatory disease that destroys the body’s ... RA patients have high concentrations of EBV DNA in their ...
Breaking Biology Technology:A deeper look at interfaces 2Cole-Parmer Begins 2014 with the Release of Preferred Solutions 2Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3
... February 28, Evotec AG (Frankfurt Stock Exchange: EVT) ... study for EVT 302 in smoking,cessation, a reversible ... This double-blind, three-way cross-over study is designed ... and withdrawal symptoms,after short-term deprivation of cigarettes in ...
... Anadys Pharmaceuticals,Inc. (Nasdaq: ANDS ) announced today ... Options in Healthcare Conference on Tuesday,March 4, 2008 at ... being,held at the W Hotel in New York., ... Anadys,Pharmaceuticals, Inc., will present an overview of Anadys and ...
... time, researchers at North Carolina State University have ... physically or chemically different so-called Janus particles ... alternating electrical field is applied to liquid surrounding ... published in the Feb. 8, 2008, edition of ...
Cached Biology Technology:Evotec Starts Phase II in Smoking Cessation with EVT 302 2Anadys Pharmaceuticals to Present at the Susquehanna SIGnificant Options in Healthcare Conference 2'2-faced' particles act like tiny submarines 2
(Date:7/9/2014)... derived from the oils produced by algae may offer ... this goal, optimization of cost effective strategies for large-scale ... needed. Sapphire Energy has developed an innovative solution to ... systems, described in Industrial Biotechnology , a peer-reviewed ... is available on the Industrial Biotechnology ...
(Date:7/9/2014)... about the prevalence of antibiotic-resistant illness, Case Western ... to disabling disease: blocking bacteria,s access to iron ... bacterial siderophore, a small molecule, captures iron from ... as well as how the body launches ... findings appear in a recent edition of ...
(Date:7/9/2014)... usually announce themselves with pain and fever but often can ... that are sneaky and hard to beat. Now, scientists have ... of tiny DNA pyramids. Published in the journal ACS ... can flag bacteria and kill more of them than medicine ... some infectious pathogens can lie in wait, undetectable in the ...
Breaking Biology News(10 mins):Controlling contamination in open algae ponds for biofuels 2Bacteria hijack plentiful iron supply source to flourish 2
... genes significantly affect variation in voter turnout, shedding new ... in the political system. The research, conducted by ... UC San Diego) and psychologist Laura A. Baker (of ... of the American Political Science Review , a ...
... from research groups around Australia, the report includes chapters ... focus on steps that can be taken to adjust ... to the Farm Writers Association of NSW in Sydney ... Howden, said it was time for agriculture to start ...
... through a tropical or temperate forest immediately impresses us ... plant world, but our knowledge of how plants are ... Now, with data emerging from many genome sequencing projects, ... architecture at the molecular level. This knowledge has ...
Cached Biology News:Why do people vote? Genetic variation in political participation 2How to build a plant 2How to build a plant 3
... the needs of the biopharmaceutical ... supports fast cell growth rates ... maintaining high cell viability and ... the Baculovirus Expression Vector System ...
Mol wt: average mol wt12,360.96 Da by calculation...
A set of five proteins which can be used to calibrate a Matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) or Electrospray Ionization (ESI) mass spectrometer....
Originally developed for the culture of Drosophila; suitable for culture of other dipteran cell lines. Powder, Insect cell culture tested...
Biology Products: